These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 23150683)

  • 1. A retrospective cohort analysis of the efficacy of adjuvant radiotherapy after primary surgical resection in patients with adrenocortical carcinoma.
    Habra MA; Ejaz S; Feng L; Das P; Deniz F; Grubbs EG; Phan A; Waguespack SG; Ayala-Ramirez M; Jimenez C; Perrier ND; Lee JE; Vassilopoulou-Sellin R
    J Clin Endocrinol Metab; 2013 Jan; 98(1):192-7. PubMed ID: 23150683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant radiation therapy improves local control after surgical resection in patients with localized adrenocortical carcinoma.
    Sabolch A; Else T; Griffith KA; Ben-Josef E; Williams A; Miller BS; Worden F; Hammer GD; Jolly S
    Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):252-9. PubMed ID: 25754631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of adjuvant radiotherapy of the tumor bed on local recurrence of adrenocortical carcinoma.
    Fassnacht M; Hahner S; Polat B; Koschker AC; Kenn W; Flentje M; Allolio B
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4501-4. PubMed ID: 16895957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant Radiation Improves Recurrence-Free Survival and Overall Survival in Adrenocortical Carcinoma.
    Gharzai LA; Green MD; Griffith KA; Else T; Mayo CS; Hesseltine E; Spratt DE; Ben-Josef E; Sabolch A; Miller BS; Worden F; Giordano TJ; Hammer GD; Jolly S
    J Clin Endocrinol Metab; 2019 Sep; 104(9):3743-3750. PubMed ID: 31220287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Outcomes of Adjuvant Mitotane Therapy in Patients With Radically Resected Adrenocortical Carcinoma.
    Berruti A; Grisanti S; Pulzer A; Claps M; Daffara F; Loli P; Mannelli M; Boscaro M; Arvat E; Tiberio G; Hahner S; Zaggia B; Porpiglia F; Volante M; Fassnacht M; Terzolo M
    J Clin Endocrinol Metab; 2017 Apr; 102(4):1358-1365. PubMed ID: 28324035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of Adjuvant Mitotane after Resection of Adrenocortical Carcinoma: A 13-Institution Study by the US Adrenocortical Carcinoma Group.
    Postlewait LM; Ethun CG; Tran TB; Prescott JD; Pawlik TM; Wang TS; Glenn J; Hatzaras I; Shenoy R; Phay JE; Keplinger K; Fields RC; Jin LX; Weber SM; Salem A; Sicklick JK; Gad S; Yopp AC; Mansour JC; Duh QY; Seiser N; Solorzano CC; Kiernan CM; Votanopoulos KI; Levine EA; Staley CA; Poultsides GA; Maithel SK
    J Am Coll Surg; 2016 Apr; 222(4):480-90. PubMed ID: 26775162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of adjuvant radiotherapy for treatment of adrenocortical carcinoma: a retrospective study and an updated meta-analysis.
    Zhu J; Zheng Z; Shen J; Lian X; Miao Z; Shen J; Zhang F
    Radiat Oncol; 2020 May; 15(1):118. PubMed ID: 32448148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of adjuvant radiation therapy in localized adrenocortical carcinoma.
    Wu L; Chen J; Su T; Jiang L; Han Y; Zhang C; Zhou W; Jiang Y; Zhong X; Wang W
    Front Endocrinol (Lausanne); 2023; 14():1308231. PubMed ID: 38260140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefit of Postoperative Radiotherapy for Patients With Nonmetastatic Adrenocortical Carcinoma: A Population-Based Analysis.
    Wu K; Liu X; Liu Z; Lu Y; Wang X; Li X
    J Natl Compr Canc Netw; 2021 Dec; 19(12):1425-1432. PubMed ID: 34902831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgery for recurrent adrenocortical carcinoma: A multicenter retrospective study.
    Simon G; Pattou F; Mirallié E; Lifante JC; Nominé C; Arnault V; de Calan L; Caillard C; Carnaille B; Brunaud L; Laplace N; Caiazzo R; Blanchard C
    Surgery; 2017 Jan; 161(1):249-256. PubMed ID: 27855966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant mitotane treatment for adrenocortical carcinoma.
    Terzolo M; Angeli A; Fassnacht M; Daffara F; Tauchmanova L; Conton PA; Rossetto R; Buci L; Sperone P; Grossrubatscher E; Reimondo G; Bollito E; Papotti M; Saeger W; Hahner S; Koschker AC; Arvat E; Ambrosi B; Loli P; Lombardi G; Mannelli M; Bruzzi P; Mantero F; Allolio B; Dogliotti L; Berruti A
    N Engl J Med; 2007 Jun; 356(23):2372-80. PubMed ID: 17554118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrence of adrenal cortical carcinoma following resection: surgery alone can achieve results equal to surgery plus mitotane.
    Grubbs EG; Callender GG; Xing Y; Perrier ND; Evans DB; Phan AT; Lee JE
    Ann Surg Oncol; 2010 Jan; 17(1):263-70. PubMed ID: 19851811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Borderline resectable adrenal cortical carcinoma: a potential role for preoperative chemotherapy.
    Bednarski BK; Habra MA; Phan A; Milton DR; Wood C; Vauthey N; Evans DB; Katz MH; Ng CS; Perrier ND; Lee JE; Grubbs EG
    World J Surg; 2014 Jun; 38(6):1318-27. PubMed ID: 24615603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant radiotherapy for the primary treatment of adrenocortical carcinoma: Are we offering the best?
    Srougi V; de Bessa J; Tanno FY; Ferreira AM; Hoff AO; Bezerra JE; Almeida CM; Almeida MQ; Mendonça BB; Nahas WC; Chambô JL; Srougi M; Fragoso MCBV
    Int Braz J Urol; 2017; 43(5):841-848. PubMed ID: 28727379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response to radiation therapy in adrenocortical carcinoma.
    Hermsen IG; Groenen YE; Dercksen MW; Theuws J; Haak HR
    J Endocrinol Invest; 2010 Nov; 33(10):712-4. PubMed ID: 20220294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant and definitive radiotherapy for adrenocortical carcinoma.
    Sabolch A; Feng M; Griffith K; Hammer G; Doherty G; Ben-Josef E
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1477-84. PubMed ID: 20675074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved survival in patients with stage II adrenocortical carcinoma followed up prospectively by specialized centers.
    Fassnacht M; Johanssen S; Fenske W; Weismann D; Agha A; Beuschlein F; Führer D; Jurowich C; Quinkler M; Petersenn S; Spahn M; Hahner S; Allolio B;
    J Clin Endocrinol Metab; 2010 Nov; 95(11):4925-32. PubMed ID: 20668036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes after resection of cortisol-secreting adrenocortical carcinoma.
    Margonis GA; Kim Y; Tran TB; Postlewait LM; Maithel SK; Wang TS; Glenn JA; Hatzaras I; Shenoy R; Phay JE; Keplinger K; Fields RC; Jin LX; Weber SM; Salem A; Sicklick JK; Gad S; Yopp AC; Mansour JC; Duh QY; Seiser N; Solorzano CC; Kiernan CM; Votanopoulos KI; Levine EA; Poultsides GA; Pawlik TM
    Am J Surg; 2016 Jun; 211(6):1106-13. PubMed ID: 26810939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes following surgical management of adrenocortical carcinoma: A single-center experience.
    Turco M; Huguet J; Territo A; Fontana M; Rodriguez Faba O; Palou J; Breda A
    Arch Esp Urol; 2021 Oct; 74(8):782-789. PubMed ID: 34605409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. National Treatment Practice for Adrenocortical Carcinoma: Have They Changed and Have We Made Any Progress?
    Tierney JF; Chivukula SV; Poirier J; Pappas SG; Schadde E; Hertl M; Kebebew E; Keutgen X
    J Clin Endocrinol Metab; 2019 Dec; 104(12):5948-5956. PubMed ID: 31361313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.